Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 millionInvivyd in vitro data showed continued ...
Bill Cassidy did not want to talk about Robert F. Kennedy Jr. Last month, as we shuffled through the U.S. Senate subway, a ...
Liberal leader Angus Taylor will roll back Labor’s controversial changes to negative gearing and capital gains tax if they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results